Literature DB >> 35270045

Correction: Vidal et al. From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment. Int. J. Mol. Sci. 2021, 22, 6740.

Silvia Vidal1, Lluís Puig1, José-Manuel Carrascosa-Carrillo2, Álvaro González-Cantero3,4, José-Carlos Ruiz-Carrascosa5, Antonio-Manuel Velasco-Pastor6.   

Abstract

In the original publication [...].

Entities:  

Year:  2022        PMID： 35270045      PMCID： PMC8910060          DOI： 10.3390/ijms23052649

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN： 1422-0067            Impact factor:   5.923


In the original publication [1], there was a mistake in Figure 1 as published. A new yellow circle has been added to clarify the action of brodalumab on IL-17A, A/F, and F. The three items named TRAF6 (colored in light green) have been substituted for the correct name: TRAF2/5. The corrected Figure 1 appears below. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original publication has also been updated.
  1 in total

Review 1.  From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment.

Authors:  Silvia Vidal; Lluís Puig; José-Manuel Carrascosa-Carrillo; Álvaro González-Cantero; José-Carlos Ruiz-Carrascosa; Antonio-Manuel Velasco-Pastor
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.